B.E. CURCUMINOIDS 7X

Serial Number 76673485
Registration 3322268
800

Registration Progress

Application Filed
Mar 2, 2007
Under Examination
Approved for Publication
Jul 25, 2007
Published for Opposition
Aug 14, 2007
Registered
Oct 30, 2007

Trademark Image

B.E. CURCUMINOIDS 7X

Basic Information

Serial Number
76673485
Registration Number
3322268
Filing Date
March 2, 2007
Registration Date
October 30, 2007
Published for Opposition
August 14, 2007
Renewal Date
October 30, 2017
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
Nov 6, 2017
Registration
Registered
Classes
005

Rights Holder

DOLCAS BIOTECH, LLC

16
Address
9 Lenel Road
Landing, NJ 07850

Ownership History

ORCAS INTERNATIONAL, INC.

Original Applicant
03
Flanders, NJ

ORCAS INTERNATIONAL, INC.

Owner at Publication
03
Flanders, NJ

ORCAS INTERNATIONAL, INC.

Original Registrant
03
Flanders, NJ

DOLCAS BIOTECH, LLC

New Owner After Registration #1
99
CHESTER, NJ

DOLCAS BIOTECH, LLC

New Owner After Registration #2
16
Landing, NJ

Legal Representation

Attorney
Carolyn A. Galgano

USPTO Deadlines

Next Deadline
724 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2007-10-30)
Due Date
October 30, 2027
Grace Period Ends
April 30, 2028

Application History

34 events
Date Code Type Description Documents
Jun 20, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 20, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 20, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 20, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 20, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 20, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 6, 2017 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Nov 6, 2017 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Nov 6, 2017 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Nov 6, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Oct 10, 2017 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Oct 30, 2016 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
May 6, 2014 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
May 6, 2014 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Apr 30, 2014 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Apr 30, 2014 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Loading...
Apr 24, 2014 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
Oct 30, 2013 PR23 O POST REGISTRATION ACTION MAILED - SEC. 8 & 15 Loading...
Oct 29, 2013 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Oct 16, 2013 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
May 23, 2008 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 12, 2007 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 30, 2007 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 14, 2007 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 25, 2007 NPUB O NOTICE OF PUBLICATION Loading...
May 19, 2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 19, 2007 ALIE A ASSIGNED TO LIE Loading...
May 3, 2007 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 30, 2007 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
Apr 30, 2007 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 30, 2007 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 18, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 13, 2007 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 8, 2007 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
NUTRITIONAL SUPPLEMENTS IN POWDER, TABLET, CAPSULE, AND LIQUID FORM
First Use Anywhere: Jun 6, 2006
First Use in Commerce: Jun 6, 2006

Additional Information

Pseudo Mark
B.E. CURCUMINOIDS SEVEN X

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
CURCUMINOIDS